Jan. 24–28, 2022 • Austin, TX
Registration Rates | 2022 Program Schedule (coming soon) | Meeting Code of Conduct
OVERVIEW
The Society for Immunotherapy of Cancer (SITC) will host its forth annual Cancer Immunotherapy Winter School, a comprehensive cancer immunotherapy education program, in Austin, TX, Jan. 24–28, 2022. Taught by leading experts in the field, this program provided a deep understanding of the core principles of tumor immunology and cancer immunotherapy as well as developing areas in the field including biomarker technology, validation and clinical integration; clinical trial design, data analysis and considerations for combination therapies.
The program was tailored to early-to-mid career scientists and clinicians in the field of cancer immunotherapy working in academic, clinical, industry and government settings as well as those new to the field. The curriculum covers the fundamentals of cancer immunotherapy and features separate tracks, including clinical and research, allowing participants to tailor their experience by selecting the educational path most relevant to their learning goals.
ORGANIZERS
- Catherine Bollard, MBChB, MD – Children’s National Hospital
- Christian Capitini, MD – University of Wisconsin-Madison
- Daniel Powell, PhD – University of Pennsylvania
Target Audience
- Early-to-mid career scientists in the field of cancer immunotherapy working in academic, clinical, industry and government settings
- Individuals new to the field working in academic, clinical, industry and government settings
NETWORKING OPPORTUNITIES
In addition to deepening their understanding of integral facets of the field of cancer immunotherapy, attendees expanded their professional network, developing new relationships with faculty and other thought leaders in this intimate setting through small group breakout sessions and networking roundtables.
LEARNING OBJECTIVES
Upon completion of the Cancer Immunotherapy Winter School, participants were able to:
- Describe the core principles of tumor immunology and cancer immunotherapy
- Discuss recent advancements in drug and biomarker technologies and their clinical application
- Explain appropriate clinical and/or preclinical trial data analysis methods and best practices in clinical and/or preclinical trial design
Travel Awards
To support young investigators and clinicians interested in attending the Cancer Immunotherapy Winter School, SITC will accept applications for travel awards, which will supplement costs for those honored to attend.
Two of the five travel awards will be reserved for those who self-identify* as individuals from an underrepresented group in the Biomedical Sciences according to the NIH definition.
A complete travel award application will include: Applicant’s Statement of Career Objectives; Applicant’s Statement of Benefit; Proof of Student/Fellow Status or Years from Such Status. Application deadline is Oct. 14 at 5 p.m. PDT.
*The information collected in response to the self-identifying process will only be viewed by SITC staff and Cancer Immunotherapy Winter School program organizers.